Blade Air Mobility Q3 revenue up 277% to $13.0M; net loss widens to $24.3M on warrant adjustments

Strata Critical Medical, Inc.

2022-Q2 EPS reported -$0.74 revenue$30,210,000

Revenue $13.0M (+277% YoY, +73% vs pre-COVID Q3 2019).
Short distance revenue $5.7M (+810% YoY, -13% vs 2019); MediMobility/jet $6.5M (+147%).
Net loss $(24.3)M vs $(1.3)M prior year, driven by $14.9M warrant liability change and $4.2M listing costs.
Adjusted EBITDA $(2.6)M vs $(1.3)M prior year; excluding public company costs, Comparable Adj. EBITDA $(0.9)M improved.
Re-launched NYC airport transfer in June; annualized run-rate ~10,000 fliers (50% of peak 2019).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.